Sunday | Evening News
Medal winning cyclist launches charity ride for Norfolk hospital appeal
A medal winning professional cyclist helped launch a charity ride at the weekend for a cause close to her heart.
HIV Is No Barrier To Successful Liver Transplant For Cancer Treatment
As people infected with HIV live longer with antiretroviral drug therapy, more of them are developing hepatocellular carcinoma , which is particularly aggressive among this population.
Benefit for Tennis Coach Tonight
The tennis coach at Alton High School is battling liver cancer, and a benefit is being held tonight.
Hep C rising in baby boomers, but can they be treated?
When Amtrak unveils the first of 70 new locomotives Monday at a plant in California, it will mark what the national passenger railroad service hopes will be a new era of better reliability, streamlined maintenance and better energy efficiency.
HIV No Barrier to Getting Liver Transplant, Study Finds
Liver transplants to treat a common type of liver cancer are a viable option for people infected with HIV, according to new research.
Leading up to The Relay For Life events in June, Action News will introduce you to different people in the community, impacted by cancer.
Proceeds to help boy with rare form of cancer
Anna Hays Polk, 4, serves up some fresh lemonade at her home to Charlene Jackson on Wednesday.
Hepatitis C virus major challenge in the region
DOHA: About 150 million people are chronically infected and at risk of developing liver cirrhosis and/or liver cancer, and more than 350,000 people die from Hepatitis C Virus related liver diseases every year, Dr Laith Abu-Raddad said last night at a community health forum in Doha.
Fairfield High School students are using a novel art project to help beat hepatitis B and reduce the burden of liver cancer in the local area.
Centre will assist Hepatitis C patients
Health advocates expect more baby boomers will screen for Hepatitis C, with the opening of a long-awaited treatment and support centre.
Bayer Initiates Phase III Trial of Stivarga? (regorafenib) Tablets in ...
Stivarga is an inhibitor of multiple kinases involved in normal cellular functions and in pathologic processes such as oncogenesis, tumor angiogenesis and maintenance of the tumor microenvironment.1 , the FDA approved Stivarga to treat patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor who have been previously ... (more)
Brave tot from Benfleet is battling one in a million cancer
A BRAVE tot from Benfleet is battling a form of liver cancer so rare it only affects one in a million children.
Screening Events Promote Hepatitis Testing and Prevention during National Hepatitis Awareness Month
Duringi 1 2National Hepatitis Awareness Month this May,i 1 2Hep B Free San Francisco, Asian Week Foundation, and National Viral Hepatitis Roundtable are helping to coordinate hepatitis screenings and a new public service announcement to highlight prevention of hepatitis B and C disease, which together cause almost all liver cancers worldwide.i ... (more)
Report highlights major failings in UK response to hepatitis C
The UK needs to "be doing so much more" in response to hepatitis C, according to a new report.
The ABC's of Hepatitis: Mayo Clinic Expert Explains Types, Prevention
Newswise - ROCHESTER, Minn. -- It's Hepatitis Awareness Month. Understanding the different forms of hepatitis, who is at risk and how it can be prevented and treated can be confusing.
Hawaii observes National Heptatis Day on May 20
In collaboration with Hep Free Hawaii, Hawaii State Department of Health clinics and other community-based sites are offering free hepatitis screenings to the public on May 20 to encourage people to find out their hepatitis B and C status.
Medina County Health Department offering free Hepatitis C screening May 20
The Medina County Health Department will offer a free Hepatitis C screening clinic with test results on Monday, May 20, 2013, from 4:30 p.m. until 7:00 p.m. at 4800 Ledgewood Drive in Medina.
Customer Interaction Solutions
Mirna Therapeutics is First to Advance MicroRNA into the Clinic for Cancer
Mirna Therapeutics, Inc., a biotechnology company pioneering microRNA replacement therapies for cancer, announced today that it has initiated a Phase 1 clinical study of MRX34, the first miRNA to advance into a human clinical trial for cancer.
Silent epidemic' affects 1 in 12 adults in Mendocino County
MCAVHN Mendocino County AIDS/Viral Hepatitis Network has a longstanding reputation as the AIDS service agency in our community, and these services will continue as long as they are needed.
Infectious diseases weigh on primary care
Internists increasingly are managing complex communicable illnesses. The American College of Physicians meeting offered the latest guidance on such diseases.